SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. GLP-1 drugs, a class of medications originally developed for ...

Clinical drug trial registrations in China hit a record last year, the country’s drug regulator said, with more than 5,000 trials reported in the latest sign of the nation’s growing pipeline of novel ...

The track is now the longest-running U.K. No. 1 in the 2020s so far. By Sophie Williams Guess who’s back, back again: Sam Fender and Olivia Dean’s “Rein Me In” has scooped its 14th non-consecutive ...

FROM always knows how to deliver a season finale. Did it wrap up every storyline successfully? No. But it did a great job of setting the stage for the final season of the most underrated show on ...

As the biotech world flocks to San Diego today for the BIO International Convention, the Department of Health and Human Services has provided plenty of conversation fodder with the announcement of a ...

Shares of Sana Biotechnology (NASDAQ:SANA) climbed ~24% in the morning hours on Wednesday, triggering several trading halts after Canadian hedge fund manager Eric Jackson said that the cell therapy ...

Parabilis develops a platform for making what it calls Helicons, helical peptides designed to slip into cells and, once there, bind to flat protein surfaces that are typically impervious to ...

U.S.-based Boulevard Bio is paying $20 million upfront (PDF) to China’s Metis TechBio for the global rights to a trispecific T-cell engager (TCE) for autoimmune diseases. The preclinical asset, dubbed ...